Literature DB >> 17327805

Properties of the stromal cell in giant cell tumor of bone.

Michelle Ghert1, Nicole Simunovic, Robert W Cowan, Nigel Colterjohn, Gurmit Singh.   

Abstract

The histiogenesis and mechanisms of bone destruction in giant cell tumor (GCT) of bone are not well understood. We asked whether the spindle-like stromal cells of GCT of bone exhibit osteoblastic properties, and whether the stromal cells produce active matrix-degrading proteases in vitro. We performed immunohistochemistry on 17 paraffin-embedded archival specimens with a pathologic diagnosis of GCT with monoclonal antibodies for the osteoblastic lineage markers osteopontin, osteonectin, and osteocalcin. The average staining grade for the 17 specimens was highest for osteonectin, followed by osteopontin, and osteocalcin. Primary cell cultures of GCT stromal cells were prepared from two fresh tumor specimens. Western blots were used on the cell lysates and media to detect osteocalcin precursor and the matrix-degrading proteases MMP-2 and MMP-9. We found the stromal cells in culture produce osteocalcin precursor, indicating osteoblastic lineage. The cells also express both the active and inactive isoforms of MMP-2 and MMP-9. Gelatinase assays confirmed the activity of the proteases in vitro. The spindle like stromal cells of GCT have characteristics of osteoblast progenitors and produce active matrix-degrading proteases. These cells may therefore play a central role in bone destruction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327805     DOI: 10.1097/BLO.0b013e31804856a1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

1.  Collagenase expression and activity in the stromal cells from giant cell tumour of bone.

Authors:  Robert W Cowan; Isabella W Y Mak; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Bone       Date:  2009-02-12       Impact factor: 4.398

2.  Intratibial injection of patient-derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse.

Authors:  Leqin Xu; Zhipeng Wu; Zhenhua Zhou; Xinghai Yang; Jianru Xiao
Journal:  Oncol Lett       Date:  2018-07-16       Impact factor: 2.967

3.  miR-181c associates with tumor relapse of high grade osteosarcoma.

Authors:  Federica Mori; Andrea Sacconi; Valeria Canu; Federica Ganci; Mariangela Novello; Vincenzo Anelli; Renato Covello; Virginia Ferraresi; Paola Muti; Roberto Biagini; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2015-06-10

4.  Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.

Authors:  Siddhant U Jain; Sima Khazaei; Dylan M Marchione; Stefan M Lundgren; Xiaoshi Wang; Daniel N Weinberg; Shriya Deshmukh; Nikoleta Juretic; Chao Lu; C David Allis; Benjamin A Garcia; Nada Jabado; Peter W Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

5.  Histopathological, immunohistochemical, and image analytic parameters characterizing the stromal component in primary and recurrent giant cell tumor of bone.

Authors:  Charu Chandra Saxena; Rajni Safaya; Neha Kawatra Madan; Shah Alam Khan; Venkateswaran K Iyer
Journal:  J Clin Orthop Trauma       Date:  2015-10-26

Review 6.  Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesion.

Authors:  Riko Kitazawa; Ryuma Haraguchi; Mana Fukushima; Sohei Kitazawa
Journal:  Histochem Cell Biol       Date:  2018-01-22       Impact factor: 4.304

7.  Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Authors:  Ahmad Al-Sukaini; Francis J Hornicek; Zachary S Peacock; Leonard B Kaban; Soldano Ferrone; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-07-19       Impact factor: 4.176

8.  Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation.

Authors:  Shalini Singh; Mohini Singh; Isabella W Y Mak; Robert Turcotte; Michelle Ghert
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  Expressional Analysis of GFP-Tagged Cells in an In Vivo Mouse Model of Giant Cell Tumor of Bone.

Authors:  S Singh; M Singh; I Mak; M Ghert
Journal:  Open Orthop J       Date:  2013-05-03

10.  Gene transfection in primary stem-like cells of giant cell tumor of bone.

Authors:  Shalini Singh; Isabella Mak; Patricia Power; Melissa Cunningham; Melissa Cunnigham; Robert Turcotte; Michelle Ghert
Journal:  Stem Cells Cloning       Date:  2010-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.